- Company Overview for NEUROCENTRX PHARMA LIMITED (SC454814)
- Filing history for NEUROCENTRX PHARMA LIMITED (SC454814)
- People for NEUROCENTRX PHARMA LIMITED (SC454814)
- More for NEUROCENTRX PHARMA LIMITED (SC454814)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
13 Jan 2025 | CH04 | Secretary's details changed for Morton Fraser Secretaries Limited on 21 October 2024 | |
16 Oct 2024 | AD01 | Registered office address changed from C/O Morton Fraser Llp 2 Lister Square Quartermile Two Edinburgh EH3 9GL Scotland to Level 5, 9 Haymarket Square Edinburgh EH3 8RY on 16 October 2024 | |
19 Jun 2024 | AA | Total exemption full accounts made up to 31 October 2023 | |
04 Jun 2024 | RESOLUTIONS |
Resolutions
|
|
28 May 2024 | CS01 | Confirmation statement made on 25 May 2024 with no updates | |
20 Jun 2023 | TM01 | Termination of appointment of Carmel Mary Reilly as a director on 16 June 2023 | |
20 Jun 2023 | AP01 | Appointment of Mr Graeme Duncan as a director on 16 June 2023 | |
02 Jun 2023 | AA | Total exemption full accounts made up to 31 October 2022 | |
29 May 2023 | CS01 | Confirmation statement made on 25 May 2023 with no updates | |
06 Feb 2023 | TM01 | Termination of appointment of Susan Elizabeth Foden as a director on 5 February 2023 | |
13 Jul 2022 | AA | Total exemption full accounts made up to 31 October 2021 | |
06 Jun 2022 | CS01 | Confirmation statement made on 25 May 2022 with updates | |
25 Mar 2022 | SH01 |
Statement of capital following an allotment of shares on 21 March 2022
|
|
25 Mar 2022 | MA | Memorandum and Articles of Association | |
25 Mar 2022 | RESOLUTIONS |
Resolutions
|
|
22 Jul 2021 | AA | Total exemption full accounts made up to 31 October 2020 | |
09 Jun 2021 | AP01 | Appointment of Susan Elizabeth Foden as a director on 8 June 2021 | |
25 May 2021 | CS01 | Confirmation statement made on 25 May 2021 with updates | |
29 Sep 2020 | RESOLUTIONS |
Resolutions
|
|
11 Aug 2020 | PSC07 | Cessation of Equity Gap Limited as a person with significant control on 12 November 2019 | |
15 Jul 2020 | CS01 | Confirmation statement made on 15 July 2020 with no updates | |
30 Apr 2020 | AA | Total exemption full accounts made up to 31 October 2019 | |
12 Nov 2019 | PSC02 | Notification of Equity Gap Limited as a person with significant control on 6 April 2016 | |
12 Nov 2019 | PSC07 | Cessation of Fraser Stuart Lusty as a person with significant control on 6 April 2016 | |
30 Sep 2019 | CS01 | Confirmation statement made on 17 July 2019 with updates |